Men with genes that increase the risk of prostate cancer should have annual checks from the age of 40, research has shown.

Prostate cancer is the most common cancer among men after skin cancer, with approximately 1 in 8 men diagnosed in their ...

Stereotactic body radiotherapy (SBRT) showed good local control and survival for limited metastatic/progressive cancers.

Former President Joe Biden is now receiving radiation therapy for his prostate cancer, a spokesperson for the former ...

One in every 8 men in the United States will develop prostate cancer, according to prostate cancer statistics released by the American Cancer Society.

A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph ...

In men with prostate cancer, prophylactic whole pelvic radiotherapy does not improve OS compared to prostate-only dose-escalated radiotherapy.

Two cancer experts go head to head, arguing the case for and against a targeted prostate cancer screening programme.

Statin use linked to better survival but higher cardiac adverse events in advanced prostate cancer patients treated with ...

A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph ...

About one in eight men will be diagnosed with prostate cancer during their lifetime, according to the American Cancer Society ...

Combining the PARP1-selective inhibitor saruparib with an androgen receptor pathway inhibitor (ARPI) demonstrated promising efficacy and safety in patients with metastatic prostate cancer, according ...